Aligos Therapeutics (ALGS) Leases (2021 - 2025)
Historic Leases for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $3.6 million.
- Aligos Therapeutics' Leases fell 3361.14% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 3361.14%. This contributed to the annual value of $5.0 million for FY2024, which is 2431.77% down from last year.
- As of Q3 2025, Aligos Therapeutics' Leases stood at $3.6 million, which was down 3361.14% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' Leases registered a high of $8.8 million during Q4 2021, and its lowest value of $3.6 million during Q3 2025.
- Moreover, its 5-year median value for Leases was $6.9 million (2021), whereas its average is $6.6 million.
- In the last 5 years, Aligos Therapeutics' Leases skyrocketed by 2598.88% in 2022 and then plummeted by 3361.14% in 2025.
- Quarter analysis of 5 years shows Aligos Therapeutics' Leases stood at $8.8 million in 2021, then dropped by 12.41% to $7.7 million in 2022, then decreased by 14.8% to $6.6 million in 2023, then dropped by 24.32% to $5.0 million in 2024, then dropped by 27.86% to $3.6 million in 2025.
- Its last three reported values are $3.6 million in Q3 2025, $4.1 million for Q2 2025, and $4.6 million during Q1 2025.